T cells bearing a chimeric antigen receptor (CAR) consisting of the fusion of human NKG2D with the intracellular domain of CD3zeta (CYAD-01) can bind eight stress ligands expressed in many cancers. The gene discussed is KLRK1; the disease is cancer.